Stephen C. Bain

28.7k total citations · 11 hit papers
251 papers, 11.7k citations indexed

About

Stephen C. Bain is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Stephen C. Bain has authored 251 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 199 papers in Endocrinology, Diabetes and Metabolism, 97 papers in Molecular Biology and 61 papers in Surgery. Recurrent topics in Stephen C. Bain's work include Diabetes Treatment and Management (152 papers), Diabetes Management and Research (103 papers) and Metabolism, Diabetes, and Cancer (85 papers). Stephen C. Bain is often cited by papers focused on Diabetes Treatment and Management (152 papers), Diabetes Management and Research (103 papers) and Metabolism, Diabetes, and Cancer (85 papers). Stephen C. Bain collaborates with scholars based in United Kingdom, Denmark and United States. Stephen C. Bain's co-authors include Anthony Barnett, John A. Todd, Ildiko Lingvay, Tina Vilsbøll, Jeffrey W. Stephens, Stephen Gough, Mansoor Husain, Manish Khanolkar, Ofri Mosenzon and Thinzar Min and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Stephen C. Bain

242 papers receiving 11.3k citations

Hit Papers

Oral Semaglutide ... 1994 2026 2004 2015 2019 1994 2004 1995 2017 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
    2019 1.2k citations Stephen C. Bain et al. profile →
  2. A genome-wide search for human type 1 diabetes susceptibility genes
    1994 964 citations Stephen C. Bain et al. profile →
  3. Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy
    2004 625 citations Stephen C. Bain et al. profile →
  4. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus
    1995 583 citations Stephen C. Bain et al. profile →
  5. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
    2017 496 citations Stephen C. Bain et al. profile →
  6. Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
    2017 340 citations Stephen C. Bain et al. profile →
  7. A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives
    2021 239 citations Stephen C. Bain et al. profile →
  8. Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
    2021 161 citations Stephen C. Bain, John B. Buse et al. Circulation profile →
  9. A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives
    2021 149 citations Marc Evans, Stephen C. Bain et al. profile →
  10. Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
    2023 91 citations Stephen C. Bain et al. profile →
  11. Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
    2025 89 citations Darren K. McGuire, Stephen C. Bain et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen C. Bain United Kingdom 49 7.3k 3.6k 3.5k 2.9k 1.3k 251 11.7k
Guntram Schernthaner Austria 60 6.2k 0.8× 2.7k 0.7× 2.9k 0.8× 1.1k 0.4× 1.4k 1.1× 227 11.0k
Avraham Karasik Israel 41 5.5k 0.7× 2.2k 0.6× 4.0k 1.1× 1.5k 0.5× 927 0.7× 126 10.8k
George Grunberger United States 52 6.9k 0.9× 3.5k 1.0× 3.2k 0.9× 1.7k 0.6× 996 0.8× 161 10.9k
Francesco Giorgino Italy 59 5.2k 0.7× 2.5k 0.7× 4.3k 1.2× 1.0k 0.4× 1.2k 0.9× 316 12.4k
Yasuhiko Iwamoto Japan 50 4.9k 0.7× 2.2k 0.6× 2.8k 0.8× 1.7k 0.6× 1.2k 1.0× 272 10.5k
Giorgio Sesti Italy 67 6.9k 0.9× 3.4k 1.0× 5.6k 1.6× 1.3k 0.5× 2.7k 2.1× 416 15.1k
Peter Almgren Sweden 48 4.8k 0.6× 2.8k 0.8× 4.3k 1.2× 2.9k 1.0× 2.1k 1.6× 142 12.6k
Michel Marre France 66 8.7k 1.2× 3.3k 0.9× 3.9k 1.1× 2.2k 0.7× 3.8k 2.9× 423 17.2k
Giatgen A. Spinas Switzerland 53 3.9k 0.5× 3.5k 1.0× 2.3k 0.6× 1.9k 0.7× 712 0.5× 145 9.2k
Lee‐Ming Chuang Taiwan 55 3.7k 0.5× 2.5k 0.7× 3.2k 0.9× 1.5k 0.5× 1.3k 1.0× 335 11.9k

Countries citing papers authored by Stephen C. Bain

Since Specialization
Citations

This map shows the geographic impact of Stephen C. Bain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen C. Bain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen C. Bain more than expected).

Fields of papers citing papers by Stephen C. Bain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen C. Bain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen C. Bain. The network helps show where Stephen C. Bain may publish in the future.

Co-authorship network of co-authors of Stephen C. Bain

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen C. Bain. A scholar is included among the top collaborators of Stephen C. Bain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen C. Bain. Stephen C. Bain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tuttle, Katherine R., et al.. (2024). Effects of Once-Weekly Semaglutide on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Trial. Kidney International Reports. 9(7). 2006–2015. 15 indexed citations
3.
4.
Bain, Stephen C., et al.. (2024). Using Artificial Intelligence to Improve the Accuracy of a Wrist-Worn, Noninvasive Glucose Monitor: A Pilot Study. Journal of Diabetes Science and Technology. 19(6). 1546–1553. 2 indexed citations
5.
6.
Moser, Othmar, James Rafferty, Max L. Eckstein, et al.. (2023). Impact of severe hypoglycaemia requiring hospitalization on mortality in people with type 1 diabetes: A national retrospective observational cohort study. Diabetes Obesity and Metabolism. 25(8). 2243–2254. 6 indexed citations
7.
Schmidt, Signe, et al.. (2023). Automated Insulin Delivery Around Exercise in Adults with Type 1 Diabetes: A Pilot Randomized Controlled Study. Diabetes Technology & Therapeutics. 25(7). 476–484. 9 indexed citations
8.
Schmidt, Signe, et al.. (2023). Glycemia Around Exercise in Adults with Type 1 Diabetes Using Automated and Nonautomated Insulin Delivery Pumps: A Switch Pilot Trial. Diabetes Technology & Therapeutics. 25(4). 287–292. 9 indexed citations
9.
Viljoen, Adie, et al.. (2022). The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK. The European Journal of Health Economics. 24(6). 895–907. 5 indexed citations
10.
Evans, Marc, et al.. (2022). The challenges and pitfalls of incorporating evidence from cardiovascular outcomes trials in health economic modelling of type 2 diabetes. Diabetes Obesity and Metabolism. 25(3). 639–648. 5 indexed citations
11.
Schmidt, Signe, et al.. (2022). Metabolic and physiological responses to graded exercise testing in individuals with type 1 diabetes using insulin pump therapy. Diabetes Obesity and Metabolism. 25(3). 878–888. 3 indexed citations
12.
Bain, Stephen C., et al.. (2021). Delivering joined-up care for people with type 2 diabetes: rationale, challenges and examples. British Journal of Diabetes. 21(1). 89–95. 2 indexed citations
13.
Dunseath, Gareth, Charlotte Jones, Max L. Eckstein, et al.. (2020). Extent and prevalence of post-exercise and nocturnal hypoglycemia following peri-exercise bolus insulin adjustments in individuals with type 1 diabetes. Nutrition Metabolism and Cardiovascular Diseases. 31(1). 227–236. 16 indexed citations
14.
Dunseath, Gareth, Charlotte Jones, Lia Bally, et al.. (2020). Metabolomic, hormonal and physiological responses to hypoglycemia versus euglycemia during exercise in adults with type 1 diabetes. BMJ Open Diabetes Research & Care. 8(1). e001577–e001577. 3 indexed citations
15.
Bain, Stephen C., Brian Bekker Hansen, Barnaby Hunt, Barrie Chubb, & William J. Valentine. (2019). Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK. Journal of Medical Economics. 23(1). 98–105. 37 indexed citations
16.
Bain, Stephen C., Brian Bekker Hansen, Samuel J. P. Malkin, et al.. (2019). Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme. Diabetes Therapy. 11(1). 259–277. 45 indexed citations
17.
Bain, Stephen C., et al.. (2019). Pharmacological treatment for Type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK. Diabetic Medicine. 36(9). 1063–1071. 4 indexed citations
18.
Verma, Subodh, Stephen C. Bain, Deepak L. Bhatt, et al.. (2018). Abstract 14806: The Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide Improve Cardiovascular and Renal Outcomes Across Most Body Mass Index Categories in Type 2 Diabetes: Results of the LEADER and SUSTAIN 6 Trials. Circulation. 3 indexed citations
19.
Davies, Melanie J., Stephen C. Bain, Stephen L. Atkin, et al.. (2015). Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial. Diabetes Care. 39(2). 222–230. 174 indexed citations
20.
Stephens, Jeffrey W., Thora Bödvarsdóttir, K. Wareham, et al.. (2011). Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 94(2). 199–206. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guntram Schernthaner Breakdown of academic impact, for papers by Avraham Karasik Breakdown of academic impact, for papers by George Grunberger Breakdown of academic impact, for papers by Francesco Giorgino Breakdown of academic impact, for papers by Yasuhiko Iwamoto Breakdown of academic impact, for papers by Giorgio Sesti Breakdown of academic impact, for papers by Peter Almgren Breakdown of academic impact, for papers by Michel Marre Breakdown of academic impact, for papers by Giatgen A. Spinas Breakdown of academic impact, for papers by Lee‐Ming Chuang
Rankless by CCL
2026